These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1209 related items for PubMed ID: 17498579

  • 1. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M, ADHERE Scientific Advisory Committee and Investigators.
    J Am Coll Cardiol; 2007 May 15; 49(19):1943-50. PubMed ID: 17498579
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE.
    Fonarow GC, Peacock WF, Horwich TB, Phillips CO, Givertz MM, Lopatin M, Wynne J, ADHERE Scientific Advisory Committee and Investigators.
    Am J Cardiol; 2008 Jan 15; 101(2):231-7. PubMed ID: 18178412
    [Abstract] [Full Text] [Related]

  • 3. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS, Peacock WF, McMullin N, Jessie R, Fonarow GC, Wynne J, Mills RM.
    J Am Coll Cardiol; 2008 Aug 12; 52(7):534-40. PubMed ID: 18687247
    [Abstract] [Full Text] [Related]

  • 4. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
    Valle R, Aspromonte N, Feola M, Milli M, Canali C, Giovinazzo P, Carbonieri E, Ceci V, Cerisano S, Barro S, Milani L.
    J Card Fail; 2005 Sep 12; 11(7):498-503. PubMed ID: 16198244
    [Abstract] [Full Text] [Related]

  • 5. Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
    Hogenhuis J, Voors AA, Jaarsma T, Hillege HL, Hoes AW, van Veldhuisen DJ.
    Am Heart J; 2006 May 12; 151(5):1012.e1-5. PubMed ID: 16644323
    [Abstract] [Full Text] [Related]

  • 6. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry.
    Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M, ADHERE Scientific Advisory Committee and Investigators.
    Am Heart J; 2007 Jan 12; 153(1):74-81. PubMed ID: 17174642
    [Abstract] [Full Text] [Related]

  • 7. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB, Hamilton MA, Fonarow GC.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):85-90. PubMed ID: 16386669
    [Abstract] [Full Text] [Related]

  • 8. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, Moriguchi M, Takeda S, Izumi T.
    J Am Coll Cardiol; 2008 Jun 17; 51(24):2329-35. PubMed ID: 18549918
    [Abstract] [Full Text] [Related]

  • 9. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
    Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, ADHERE Scientific Advisory Committee and Investigators.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):76-84. PubMed ID: 16386668
    [Abstract] [Full Text] [Related]

  • 10. [Comparative value of B-type natriuretic peptide and serum albumin concentration in the prediction of in-hospital mortality in elderly patients admitted for acute severe heart failure].
    Arques S, Pieri B, Biegle G, Roux E, Gelisse R, Jauffret B.
    Ann Cardiol Angeiol (Paris); 2009 Nov 03; 58(5):279-83. PubMed ID: 19819420
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic and prognostic significance of plasma N-terminal-pro-brain natriuretic peptide in decompensated heart failure with preserved ejection fraction.
    Paul B, Soon KH, Dunne J, De Pasquale CG.
    Heart Lung Circ; 2008 Dec 03; 17(6):497-501. PubMed ID: 18722158
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 13. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
    Arquès S, Roux E, Sbragia P, Pieri B, Gélisse R, Luccioni R, Ambrosi P.
    Arch Mal Coeur Vaiss; 2007 Feb 15; 100(2):113-20. PubMed ID: 17474496
    [Abstract] [Full Text] [Related]

  • 14. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.
    J Am Coll Cardiol; 2008 May 13; 51(19):1874-82. PubMed ID: 18466803
    [Abstract] [Full Text] [Related]

  • 15. Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure.
    Horwich TB, Hernandez AF, Dai D, Yancy CW, Fonarow GC.
    Am Heart J; 2008 Dec 13; 156(6):1170-6. PubMed ID: 19033015
    [Abstract] [Full Text] [Related]

  • 16. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.
    J Am Coll Cardiol; 2008 Jul 22; 52(4):266-72. PubMed ID: 18634981
    [Abstract] [Full Text] [Related]

  • 17. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton CM, Crozier IG, Yandle TG, Doughty R, MacMahon S, Sharpe N, Christchurch Cardioendocrine Research Group, Australia-New Zealand Heart Failure Group.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):52-60. PubMed ID: 16386664
    [Abstract] [Full Text] [Related]

  • 18. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R, Aspromonte N, Giovinazzo P, Carbonieri E, Chiatto M, di Tano G, Feola M, Milli M, Fontebasso A, Barro S, Bardellotto S, Milani L.
    J Card Fail; 2008 Apr 03; 14(3):219-24. PubMed ID: 18381185
    [Abstract] [Full Text] [Related]

  • 19. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M.
    Crit Care Med; 2006 Aug 03; 34(8):2140-4. PubMed ID: 16763507
    [Abstract] [Full Text] [Related]

  • 20. [Prognostic value of BNP for hospital mortality in elderly subjects hospitalised for acute diastolic cardiac failure].
    Arques S, Roux E, Sbragia P, Pieri B, Gélisse R, Ambrosi P.
    Arch Mal Coeur Vaiss; 2006 Mar 03; 99(3):210-4. PubMed ID: 16618023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.